Johnson & Johnson agrees to $5.5B comprehensive resolution of ovarian talc litigation

JOHNSON & JOHNSON

Agreement with plaintiff firms leading federal MDL and state court proceedings, conditioned on at least 95% participation of remaining claims.
$5.5 billion total commitment; first payment of up to $3 billion in 2027, no further payments before 2028.
Per claim payment structure under the comprehensive resolution.
Resolution covers ovarian talc litigation, a major ongoing legal matter for JNJ.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.